Background and Purpose-The effects of aneurysm treatment modality (clipping or coiling) on the incidence of cerebral vasospasm and infarction after subarachnoid hemorrhage have not been clearly defined. We hypothesized that there may be a difference in angiographic and clinical vasospasm, cerebral infarction, and clinical outcome between patients undergoing clipping compared to coiling. Methods-A retrospective, exploratory analysis of 413 patients randomized into the CONSCIOUS-1 trial was conducted.
P revious work examined differences in the incidence of vasospasm between coiling and clipping. The results have been equivocal, with some studies demonstrating no difference 1,2 and others demonstrating a higher incidence of vasospasm after craniotomy and clipping. 3, 4 Most studies examined symptomatic vasospasm and were retrospective, rendering them susceptible to many types of bias.
The Clazosentan to Overcome Neurological Ischemia and Infarction Occurring After Subarachnoid Hemorrhage (CONSCIOUS-1) study examined the endothelin-1 antagonist, clazosentan, for prevention of cerebral vasospasm. 5 This study demonstrated a dose-dependent reduction in angiographic vasospasm in patients with subarachnoid hemorrhage (SAH) treated with clazosentan. All patients underwent baseline and follow-up catheter angiography that was reviewed and quantified in a centralized blinded fashion. Because patients in CONSCIOUS-1 underwent clipping or coiling, the data can be used to assess effects of clipping and coiling on a variety of end points, including cerebral vasospasm.
The primary objective of this exploratory analysis was to investigate whether the rates of angiographic vasospasm, delayed ischemic neurological deficits (DIND), cerebral infarction, and clinical outcome were different between clipped and coiled patients in the CONSCIOUS-1 study when controlling for differences in baseline prognostic risk factors.
Materials and Methods

Design and Patients
Details of the CONSCIOUS-1 study have been reported. 5 This was a phase IIb randomized, double-blind, placebo-controlled, dosefinding study examining clazosentan (1, 5 , or 15 mg/h [1:1:1:1]) conducted at 52 centers in 11 countries. Enrolled patients were 18 to 70 years old with SAH attributable to a ruptured saccular aneurysm. For inclusion in the study, the subarachnoid clot on CT had to be either diffuse (long axis Ն20 mm) or localized (long axis Ͻ20 mm) and thick (short axis Ͼ4 mm). Patients had World Federation of Neurosurgical Societies (WFNS) grade 1 to 4. Placebo or clazosentan was started intravenously within 56 hours of hemorrhage and continued for 14 days from the hemorrhage. Aneurysm clipping or coiling was performed within 12 hours of initiation of clazosentan infusion. The method of securing the aneurysm was determined by the treating physician. All patients had digital subtraction angiography within 48 hours of SAH, before the aneurysm-securing procedure, and at 9Ϯ2 days after SAH. A CT scan was performed on admission within 48 hours of SAH, 24 to 28 hours after the aneurysm-securing procedure, 6 weeks after SAH, and on any worsening of the neurological examination.
End points were vasospasm (angiographic and DIND) and the appearance of a new cerebral infarction on CT scan within 6 weeks of SAH and the extended Glasgow outcome score (eGOS) and modified Rankin scale assessed 3 months after SAH. 6, 7 The eGOS was classified as favorable (good recovery or moderate disability) or unfavorable (severe disability, vegetative, or dead) and the modified Rankin scale was classified similarly as favorable (0 -3) or unfavorable (4 -6) or as favorable (0 -2) or unfavorable (3) (4) (5) (6) . Only results for eGOS are presented because those for the modified Rankin scale were essentially identical for both cut points for dichotomization of the modified Rankin scale. Radiology was reviewed centrally by 2 independent blinded reviewers. Angiographic vasospasm was graded as none/mild, moderate, or severe based on global and quantitative assessment of digital subtraction angiography. Disagreements between reviewers were adjudicated to reach a consensus. DIND was defined by the investigators as vasospasm on digital subtraction angiography or transcranial Doppler associated with neurological worsening lasting for at least 2 hours with no other explanation. Cerebral infarction was diagnosed as new hypodensity on CT scan compared to the 24-to 48-hour postaneurysm treatment CT scan that was not attributable to intracerebral hemorrhage, ventricular drain placement, or some other nonvascular etiology. This was also based on adjudicated central radiology review and included infarction caused by vasospasm and by unknown cause.
Statistical Analysis
Two exploratory analyses were performed on the all-randomized data set (nϭ413) with or without imputation for missing end points (angiographic vasospasm and eGOS). The imputation rules were to assume moderate/severe vasospasm if information on angiographic vasospasm was missing unless the patient was alive at follow-up, completed the study treatment, and had no transcranial Doppler findings or clinical symptoms of neurological worsening. For this analysis, if the eGOS was missing, then the patient was assumed to have died.
First, the probabilities of angiographic vasospasm, DIND, cerebral infarction, and clinical outcome in patients who had undergone either coiling or clipping of a ruptured aneurysm were modeled on independent variables using multiple logistic regressions. The backward selection method was used to remove redundant and nonsignificant variables from the initial models, with P for removal set at 0.05.
To address the small sample size in select groups, some of the categorical variables with low patient distribution were collapsed into fewer categories. Admission WFNS grade was collapsed from 5 to 3 grades (1, 2 to 3, and 4 to 5); location of the ruptured aneurysm was classified into anterior cerebral artery, internal cerebral artery, Independent variables were gender, phenytoin use, history of hypertension, use of calcium channel antagonists, ventricular or lumbar drainage, intraventricular hemorrhage, intracerebral hemorrhage, and body temperature Ͼ38°C for a total of 7 to 9 days. The 2 and Fisher exact tests were performed to check for association between these variables (derived or existing) and the selected outcome measures (angiographic vasospasm, DIND, cerebral infarction, and eGOS). Independent variables that were significant at the 5% level were entered into the multivariable logistic regression. Adjusted odds ratios with 95% confidence intervals were calculated and significance was considered at PϽ0.05. The reference groups for calculation and comparison effects of odds ratios were male, younger than 65 years old, WFNS grade 1, local clot, 16-mm aneurysm, and posterior circulation location, with no history of hypertension and no use of phenytoin or ventricular or lumbar drainage.
Because the method of aneurysm securing (clipping or coiling) was not randomly assigned in CONSCIOUS-1, a second analysis was performed using propensity matching. 8 -10 The propensity for the aneurysm-securing procedure was determined using multivariable logistic regression based on baseline (demographic, medical history, procedural) variables. No interaction variables were entered. Center effect was controlled by Malahanobis distance matching. We used 1-to-1 matching based on nearest neighbor within caliper and Mahalanobis with and without propensity score (SAS Institute). The final propensity score used Mahalanobis with propensity score. The c-statistic for the propensity score derivation model was 0.74, indicating a strong ability to discriminate between patients undergoing clipping or coiling. These scores were then used to individually match patients undergoing clipping to unique control patients undergoing coiling. End points were then compared between clipping and coiling on the propensity-matched patients using univariate statistics.
Results
Baseline Characteristics
Baseline data for the all-randomized population and propensity-matched pairs show that both were similar in terms of baseline characteristics except for aneurysm location, where the propensity-matched pairs had more internal carotid and middle cerebral artery and fewer posterior circulation aneurysms (Table 1 ). Significant differences in characteristics that could affect angiographic vasospasm, DIND, cerebral infarction, or eGOS in the all-randomized population undergoing clipping or coiling were ventriculostomy (50% vs 40% respectively; PϽ0.05) and calcium channel antagonist use (81% vs 96% respectively; PϽ0.0001).
Factors Associated With Angiographic Vasospasm, DIND, New Infarction, and eGOS Using Univariate Analysis
Univariate analysis showed angiographic vasospasm was associated with female gender, ventriculostomy, thick subarachnoid clot, intracerebral hemorrhage, phenytoin use, clipping, and WFNS grade (PϽ0.05). Treatment with clazosentan (at all doses) and calcium channel antagonists were associated with decreased angiographic vasospasm (PϽ0.05). DIND was associated with ventriculostomy, clipping, thick subarachnoid clot, intracerebral hemorrhage, history of hypertension, phenytoin use, and WFNS grade (PϽ0.05). Cerebral infarction was associated with ventriculostomy, fever, history of hypertension, phenytoin use, intracerebral hemorrhage, thick subarachnoid clot, aneurysm size, and WFNS grade (PϽ0.05). Unfavorable eGOS was associated with age older than 65, male gender, thick subarachnoid clot, history of hypertension, intracerebral hemorrhage, use of rescue therapy, 5 ventriculostomy, and WFNS grade, whereas the use of calcium channel antagonists was associated with favorable eGOS (PϽ0.05).
Factors Associated With Angiographic Vasospasm, DIND, New Infarction, and eGOS in Multivariable Models
Multivariable analysis indicated that female gender, ventriculostomy, thick subarachnoid clot, intracerebral hemorrhage, phenytoin, and clipping were associated with angiographic vasospasm, whereas the significant clazosentan treatment effect, observed in the clinical trial, remained in the presence of the other factors in the model (Table 2) . Imputation for the missing angiographic vasospasm values eliminated the significant association of ventriculostomy and revealed a significant association of calcium channel antagonists with angiographic vasospasm in addition to the aforementioned predictor variables (Table 2) .
Variables significantly associated with DIND were ventriculostomy, clipping, thick clot size, intracerebral hemorrhage, and history of hypertension (Table 2 ). Factors associated with cerebral infarction were use of phenytoin, history of hypertension, intracerebral hemorrhage, and WFNS grade. Clipping was not associated with cerebral infarction (Table 2) .
Factors associated with unfavorable outcome on the eGOS at 90 days were history of hypertension, older age (Ͼ65 years), and WFNS grade. The method of aneurysm treatment was not associated with outcome (Table 2) .
Clipping and Clinical Outcomes in Propensity-Matched Patients
Logistic regression was used to generate a propensity score to associate clipping with 10 variables (age, gender, WFNS grade, subarachnoid clot size, aneurysm size and location, hypertension, intraventricular hemorrhage, intracerebral hemorrhage, and hydrocephalus). Of the 199 patients who underwent clipping, 102 were matched to patients undergoing coiling (Table 1) . Propensity matching eliminated the significant differences between clipped and coiled patients in aneurysm size, location, and use of ventriculostomy, but there were still significantly more patients with coiling treated with calcium channel antagonists (95% vs 81%; PϽ0.005).
Propensity analysis also eliminated the significant association of phenytoin and gender on angiographic vasospasm and eliminated the effect of clipping or coiling on DIND, as well as the effect of subarachnoid clot thickness and intracerebral hemorrhage on cerebral infarction. Clinical outcome was related only to WFNS grade, age, and calcium channel antagonists in the propensity-matched analysis. History of hypertension became insignificant (Table 3) . 
Adjusted Rates of Angiographic Vasospasm and DIND
Finally, we calculated event rates of angiographic vasospasm and DIND after modeling these variables on the aneurysm treatment modality with and without adjustments for confounders (Table 4) . Patients who underwent coiling had angiographic vasospasm and DIND rates of 36% and 15%, respectively, compared to 55% and 23% in the clipped group. Adjusting for confounders increased the discrepancy between the 2 groups (Table 4) .
Discussion
This exploratory analysis suggests that the type of procedure used to secure a ruptured aneurysm is significantly associated with the risk of angiographic vasospasm and DIND, although the method of aneurysm-securing has a weaker relation to development of cerebral infarction. The data for this exploratory analysis were extracted from the CONSCIOUS-1 trial, a study designed to evaluate the efficacy of clazosentan in preventing cerebral vasospasm secondary to SAH. This study showed a reduction in moderate or severe vasospasm from 66% in the placebo group to 23% in the group receiving a 15-mg/hr infusion of clazosentan (risk reduction, 65%; 95% confidence interval, 47%-78%; PϽ0.0001). 5 Although the primary goal of CONSCIOUS-1 was to evaluate the effect of clazosentan on angiographic vasospasm, the data collected provide a unique opportunity to examine the effect of clipping or coiling on a variety of end points because all patients underwent angiography at baseline and during the vasospasm interval, and radiographic studies were blindly examined through a blinded central review process.
Whether clipping or coiling is associated with an increased risk of cerebral vasospasm has been debated. There are analyses reporting that symptomatic vasospasm is the same, 2 more common, 3, 4, 11 or less common 12 after surgical clipping compared to coiling. All of these studies have shortcomings, such as their retrospective nature, lack of angiographic diagnosis of vasospasm, and varying definitions of DIND. The effect of method of aneurysm treatment on angiographic vasospasm remains controversial. A meta-analysis of literature comparing the incidence of vasospasm after clipping or coiling included 2400 patients from 9 studies and concluded that there was no statistically significant difference in vasospasm rates between patients who were treated with surgical clipping and those treated endovascularly. 1 It is a matter of speculation as to why the mode of aneurysm treatment might affect vasospasm. There are convincing arguments why surgical treatment may decrease vasospasm. The presence of clot, specifically red blood cells, is a critical component in the pathogenesis of cerebral vasospasm. [13] [14] [15] [16] [17] [18] [19] Because of this, it has been suggested that removal of cisternal blood during surgical clipping may decrease the risk of vasospasm. 20 However, although they do appear to decrease vasospasm, investigations examining clot removal and thrombolysis, 21, 22 including a randomized prospective trial, 23 have failed to produce consistent data regarding this practice. 24 -26 An argument against this is that treatment with endovascular coiling fails to remove any subarachnoid clot, yet the rates of vasospasm in some series, including this one, is decreased when compared to clipping. Although the increased rates of vasospasm seen with clipping as opposed to coiling seem to provide evidence against clot removal, this observation may be attributable to other factors. For example, craniotomy with brain retraction and surgical manipulation of blood vessels may exacerbate preexisting vasospasm. 24, 25, 27, 28 Therefore, although decreasing the clot burden theoretically contributes to lowering the rates of vasospasm, this beneficial effect could be negated by other effects associated with surgery.
Previous studies reported an association between vasospasm and cerebral infarction. 4,29 -32 Therefore, an increase in angiographic vasospasm attributable to surgical clipping also should be associated with increased cerebral infarction. This was not the case in this analysis. Previous literature on this question is conflicting with studies concluding infarction is more likely after surgery 4 or coiling. 33 One reason for the lack of association found in the present study may be that the sample size was too small. Another is that infarcts were assessed on CT scans and other imaging modalities, like MRI, may detect more lesions after SAH. It could be hypothesized that these might occur with different frequencies in patients undergoing clipping or coiling, as was suggested in 1 study. 34 That endovascular coiling was associated with better outcome than neurosurgical clipping in a large randomized trial, although the present study did not show a difference in outcome between the treatment methods, which argues in favor of this. 35, 36 Another reason for the lack of association of clipping or coiling with outcome in this study, despite the association with angiographic vasospasm, could be insensitivity of the dichotomous eGOS to small differences in outcome.
Conclusion
Exploratory analysis of 413 patients randomized into the CONSCIOUS-1 trial indicated through multivariable analysis that surgical clipping of a ruptured aneurysm was independently associated with angiographic vasospasm and DIND, although it was not associated with an increased risk of cerebral infarction on CT scan. The limitations of this analysis include that patients were not randomized to clipping or coiling. There were significant differences in use of ventriculostomy and calcium channel antagonists that could influence the results, and only the difference in ventriculostomy was adjusted with propensity matching. Furthermore, we do not have data on effects of method of aneurysm treatment on other factors that may affect DIND and cerebral infarction, such as microcirculatory changes.
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